Cardiac amyloidosis

Cardiac amyloidosis (CA) is increasingly identified due to advances in diagnostics and therapy in recent decades, especially in the field of transthyretin-related CA. Searching for CA in specific settings identifies a relatively large number of cases that may be eligible for treatment if the diagnosis is unequivocal. Through the use of clinical and instrumental red flags it is possible to quickly arrive at the suspicion of CA. Then, through the well-known diagnostic flow chart, to a certain and definitive diagnosis.